Quality Systems No Longer Theoretical as Industry Begins Implementing Concepts
This article was originally published in The Gold Sheet
Alignment of reality with ICH quality systems theory is under way. Industry is developing, promoting and implementing global solutions through ISPE's new PQLI process, with the involvement of regional regulators. Conformia's new, more complex mock P2 could kindle more QbD. Genentech's approach to QbD described in detail. Quality systems seen as an option you can't refuse. Lessons from the device sector. Why Lilly switched to quality systems and how it benefited. How Abbott prepares for the future with management reviews. What Amgen did to correct its CAPA process - and save millions of dollars along the way
You may also be interested in...
Quest for accountability and root cause seen in latest FDA warning letters. FDA, Congress pressure McNeil, J&J. 'Phantom recall' debated. Is propofol too hard for Teva, Hospira to make? Perrigo raked over tablet mix-ups. Braintree learns to fear spiders. Merck unit goes OOS. Splitting hairs over Shamrock's tablet splitting? Pierre Fabre: Three batches and you're out?
The US FDA shaved months from review of Gilead’s Veklury (remdesivir) for COVID-19 with post-approval commitments for multiple stability studies. The Pink Sheet takes a deep dive look at discussions within the agency and with the sponsor.